Cosmos Remedies Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 29-12-2024
- Paid Up Capital ₹ 2.03 Cr
as on 29-12-2024
- Company Age 28 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 2.90 Cr
as on 29-12-2024
- Revenue %
(FY 2022)
- Ebitda
- Net Worth -0.02%
(FY 2022)
- Total Assets %
(FY 2022)
About Cosmos Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.03 Cr.
The company has closed loans amounting to ₹2.90 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vivek Hundlani, Sandhya Hundlani, and Sandeep Ahuja serve as directors at the Company.
- CIN/LLPIN
U24231GJ1996PLC029657
- Company No.
029657
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 May 1996
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- LocationNa, Gujarat
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cosmos Remedies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Hundlani  | Director | 25-Jul-2009 | Current |
| Sandhya Hundlani | Director | 25-Jul-2009 | Current |
| Sandeep Ahuja | Director | 25-Jul-2011 | Current |
Financial Performance of Cosmos Remedies.
Cosmos Remedies Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Cosmos Remedies?
In 2021, Cosmos Remedies had a promoter holding of 20.69% and a public holding of 79.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Regent Healthcare LimitedActive 18 years 11 monthsVivek Hundlani, Sandhya Hundlani and 1 more are mutual person
- Boscogen Overseas LimitedActive 30 years 28 days
Vivek Hundlani, Sandhya Hundlani and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 17 Apr 2010 | ₹7.00 M | Satisfied |
Bank Of India Creation Date: 17 Apr 2010 | ₹7.00 M | Satisfied |
Oriental Bank Of Commerce Creation Date: 18 Mar 1997 | ₹7.50 M | Satisfied |
How Many Employees Work at Cosmos Remedies?
Unlock and access historical data on people associated with Cosmos Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cosmos Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cosmos Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
